For
UK
audiences
The professional's guide to product selection
The professional's guide to product selection
Roflumilast is a phosphodiesterase type-4 inhibitor with anti-inflammatory properties.
• Adult: 250 mcg once daily for 28 days, then 500 mcg once daily for maintenance.
• Child 1 month–11 years: 0.25–1.5 mg/kg daily (or on alternate days), increased if necessary up to 2.4 mg/kg daily (maximum 120 mg).
• Child 12–17 years: 3–18 mg once daily or on alternate days), increased if necessary up to 2.4 mg/kg daily (maximum 120 mg).
• Adult: 3–18 mg daily for maintenance. Acute disorders, initially up to 120 mg daily.
Non-sedating antihistamine.
• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.
Non-sedating antihistamine.
• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.
Non-sedating antihistamine.
• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.
Non-sedating antihistamine.
• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.
Non-sedating antihistamine.
• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.
Non-sedating antihistamine.
• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.
Non-sedating antihistamine.
• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.
Non-sedating antihistamine.
• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.